Mina Fahim is the CEO and President of MediView XR, a Cleveland-based medical technology company giving clinicians a form of 3D 'X-ray vision' by fusing CT scans and live ultrasound into holograms surgeons can see through a headset. A University of Minnesota-trained biomedical engineer and former Medtronic research engineer, he helped steer MediView to the first FDA 510(k) clearance for an AR device that combines live imaging with 3D XR visualization (the XR90), a $24M Series A led by GE HealthCare, and the world's first-in-human AR tumor ablation at the Cleveland Clinic. His mantra: simplify, democratize, and inform care.
MediView XR is a Cleveland, Ohio med-tech company building augmented-reality 'X-ray vision' for surgeons. Founded in 2017 on Cleveland Clinic intellectual property, MediView's FDA-cleared XR90 platform and OmnifyXR Interventional Suite let clinicians see a patient's 3D anatomy - bone, tissue, organs, and vasculature - holographically projected through the skin during minimally invasive, ultrasound-guided procedures. Backed by GE HealthCare, Mayo Clinic, and Cleveland Clinic, the company raised a $24M Series A in October 2025.